Institut de virologie du CHU de Strasbourg

Institut de virologie du CHU de Strasbourg is the clinical and research virology laboratory based at the Centre hospitalier universitaire de Strasbourg in Strasbourg, Bas-Rhin. The institute provides diagnostic virology, outbreak response, translational research and training linked to regional, national and international partners such as Agence nationale de sécurité du médicament et des produits de santé, Institut Pasteur, and World Health Organization. It functions within the hospital network of the Grand Est region and interfaces with academic units at the University of Strasbourg.

History

The laboratory traces origins to hospital microbiology services in the 20th century that expanded alongside advances from Louis Pasteur-inspired institutions and post-war biomedical modernization in France. During the late 20th century it aligned with national initiatives such as the creation of reference centers like the Centre national de référence network and responded to emergent threats exemplified by the HIV/AIDS pandemic, Hepatitis C virus discovery, and the 2009 flu pandemic. In the 21st century, the institute adapted to genomic-era virology influenced by projects associated with European Molecular Biology Laboratory, Institut Pasteur, and collaborations with Inserm units, while participating in public health responses to Ebola virus epidemic in West Africa, Zika virus outbreak, and the COVID-19 pandemic.

Organization and Facilities

The institute is organized into diagnostic, molecular research, biosafety, and administrative units reporting to the Centre hospitalier universitaire de Strasbourg executive and linked academically to the University of Strasbourg and research bodies including CNRS and Inserm. Laboratory infrastructure comprises biosafety level suites compatible with clinical virology workflows, high-throughput sequencing platforms akin to those used by Genomics England projects, real-time PCR systems parallel to tools used in Centers for Disease Control and Prevention laboratories, and biobanking facilities cooperating with regional biorepositories such as French Biobank Network. Support services include bioinformatics nodes modeled after European Bioinformatics Institute practices and quality management aligned with standards from Agence nationale de sécurité du médicament et des produits de santé and accreditation systems like ISO 15189.

Research and Diagnostic Activities

The institute performs routine diagnostics for pathogens including SARS-CoV-2, influenza, respiratory syncytial virus, hepatitis B virus, hepatitis C virus, and HIV/AIDS agents, integrating molecular assays, serology, viral culture, and next-generation sequencing strategies influenced by protocols from Institut Pasteur and European Centre for Disease Prevention and Control. Research programs cover viral pathogenesis, antiviral resistance, vaccine evaluation, and genomic surveillance linked to consortia such as GISAID and collaborations with European Molecular Biology Laboratory groups. Translational studies involve partnerships with pharmaceutical developers like Sanofi and biotech firms and clinical trial networks comparable to REACT or INSERM-REACTing. The institute contributes sequence data to international databases and to epidemiological modeling efforts used by Santé publique France and World Health Organization advisory committees.

Public Health Role and Collaborations

Acting as a regional reference laboratory, the institute coordinates with Santé publique France, regional hospitals in Grand Est, and emergency preparedness agencies modeled after European Centre for Disease Prevention and Control protocols. It supports outbreak investigations, vaccination program monitoring connected with European Medicines Agency recommendations, and antimicrobial stewardship initiatives aligned with World Health Organization guidelines. International collaborations include links with Institut Pasteur de Guyane, laboratory networks in Germany, Switzerland, and partnerships with research centers such as Hôpitaux Universitaires de Genève and Charité – Universitätsmedizin Berlin. The institute also contributes expertise to training programs at the University of Strasbourg and to capacity-building projects funded through mechanisms like Horizon 2020 and bilateral cooperation with Agence française de développement.

Notable Faculty and Contributions

Faculty and staff have included clinical virologists and researchers who have published on topics ranging from molecular diagnostics to outbreak response, collaborating with investigators at Institut Pasteur, CNRS, and Inserm. The institute contributed to regional SARS-CoV-2 genomic surveillance datasets used by GISAID and to multicenter studies on antiviral therapies and vaccine effectiveness similar to publications from European Centre for Disease Prevention and Control-linked consortia. Its teams have participated in guideline development with Santé publique France and in expert panels convened by World Health Organization technical working groups. Cross-disciplinary work with clinicians from Hôpital de Hautepierre, immunologists at the University of Strasbourg Faculty of Medicine, and epidemiologists associated with Agence régionale de santé has informed regional infectious disease management and academic training programs.

Category:Medical research institutes in France Category:Hospitals in Strasbourg Category:Virology